Johnson & Johnson could soon have another blockbuster on their hands.
Aurinia Pharmaceuticals saw its shares plunge on Monday after releasing data related to its lupus therapy, voclosporin.
Generally speaking, the ACS market is a highly lucrative area for pharmaceutical companies to invest in drug development.
This collaboration will take place in two phases.
The current major players in the market, including Bayer and Novartis, are expected to maintain their strong positions.
A new home has officially been created for Biogen’s hemophilia treatments.
Valeant Pharmaceuticals is reportedly in early talks to sell Relistor, a tablet for treating opioid-induced constipation.
Researchers announced promising results for what could be the first new asthma pill in nearly 20 years.
A number of major barriers will hinder the growth of the atrial fibrillation space.
The public’s concerns are a striking example of the need to rapidly combat emerging infectious diseases.